Patents by Inventor Mathieu SCHUE

Mathieu SCHUE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4-PHENYL-TETRAHYDROPYRIDINE DERIVATIVES FOR TREATING HEARING DISEASES
    Publication number: 20230390273
    Abstract: 4-phenyl-tetrahydropyridine derivatives for use in the treatment of hearing diseases, in particular in the treatment of unilateral or bilateral sensorineural hearing loss and/or of cochlear synaptopathy optionally combined with tinnitus. Also, a pharmaceutical composition allowing a trans-tympanic administration of 4-phenyl-tetrahydropyridine derivatives and to the pharmaceutical composition for use in the treatment of hearing diseases, in particular in the treatment of unilateral or bilateral sensorineural hearing loss and/or of cochlear synaptopathy optionally combined with tinnitus.
    Type: Application
    Filed: July 5, 2023
    Publication date: December 7, 2023
    Applicant: CILCARE DEV
    Inventors: Célia BELLINE, Marie-Pierre PASDELOU, Sylvie PUCHEU, Gaëlle NAERT, Cyrille SAGE, Mathieu SCHUE
  • NON-PORCINE FORMULATIONS AND METHODS THEREOF
    Publication number: 20230210782
    Abstract: Disclosed are compositions and formulations of non-porcine lipase and methods of treatment and manufacture thereof.
    Type: Application
    Filed: June 17, 2021
    Publication date: July 6, 2023
    Inventors: Dinesh Srinivasan, James Pennington, Ted Stover, Mathieu Schue
  • HYBRID PROTEINACEOUS MOLECULE CAPABLE OF INHIBITING AT LEAST ONE ANTIBIOTIC AND PHARMACEUTICAL COMPOSITION CONTAINING IT
    Publication number: 20170354706
    Abstract: The invention relates to a hybrid proteinaceous molecule comprising at least two proteins capable of inhibiting the activity of at least one antibiotic, the proteins each having different biochemical properties and being bonded to one another. The hybrid proteinaceous molecule inhibits the activity of a least one antibiotic in order to reduce the intestinal side effects of antibiotics, such as severe diarrhoea caused by the antibiotics, and nosocomial infections secondary to parenteral antibiotic therapy.
    Type: Application
    Filed: October 13, 2015
    Publication date: December 14, 2017
    Inventors: Daniel DUPRET, Mathieu SCHUE, Philippe JAIS